Recurrence rate of atrial fibrillation after the first clinical episode: A prospective evaluation using continuous cardiac rhythm monitoring
- PMID: 29761516
- PMCID: PMC6489953
- DOI: 10.1002/clc.22904
Recurrence rate of atrial fibrillation after the first clinical episode: A prospective evaluation using continuous cardiac rhythm monitoring
Abstract
Background: Decision making regarding a patient who has experienced a first clinical episode of atrial fibrillation (AF) is challenging, and the AF recurrences should be a significant consideration. Continuous long-term rhythm monitoring via implantable loop recorders (ILRs) has enabled us to evaluate the AF recurrence profile after the first clinical episode and to investigate clinical parameters associated with the course of the arrhythmia.
Hypothesis: Continuous rhythm monitoring via ILRs in AF patients after the first clinical episode is of clinical significance and precisely evaluate the AF recurrence profile.
Methods: Thirty consecutive patients with paroxysmal AF received an ILR after their first symptomatic episode. We evaluated the maximum duration of episodes and the recurrence rate of the arrhythmia during a follow-up period of 3 years.
Results: Three patients (10%) had no AF recurrence, whereas 4 patients (13.3%) presented only 1 episode. Almost half of the patients (46.7%) had a low recurrence rate (<5 episodes/year), whereas the majority of patients (19/30) suffered from episodes with maximum duration ≤24 hours. Eleven patients (36.7%) presented either no episode or a low recurrence rate with episodes lasting ≤24 hours. The use of statins was greater in patients with a low recurrence rate (P = 0.025).
Conclusions: A significant percentage of patients either suffer no AF recurrence after their first symptomatic episode or show a low recurrence rate. Most patients present episodes of short duration. If these findings are confirmed in larger studies, they could have clinical implications ensuring individualized management of the arrhythmia in the future.
Keywords: Anticoagulation; Arrhythmia; Atrial Fibrillation; Continuous Monitoring; Implantable Loop Recorder.
© 2018 Wiley Periodicals, Inc.
Conflict of interest statement
Emmanuel N. Simantirakis received a research grant from Medtronic Inc. (A 1065096 and SQ‐1679).
Figures
References
-
- Pappone C, Radinovic A, Manguso F, et al. Atrial fibrillation progression and management: a 5‐year prospective follow‐up study. Heart Rhythm. 2008;5:1501–1507. - PubMed
-
- Simantirakis EN, Papakonstantinou PE, Chlouverakis GI, et al. Asymptomatic versus symptomatic episodes in patients with paroxysmal atrial fibrillation via long‐term monitoring with implantable loop recorders. Int J Cardiol. 2017;231:125–130. - PubMed
-
- Hindricks G, Piorkowski C, Tanner H, et al. Perception of atrial fibrillation before and after radiofrequency catheter ablation: relevance of asymptomatic arrhythmia recurrence. Circulation. 2005;112:307–313. - PubMed
-
- Flaker GC, Belew K, Beckman K, et al. Asymptomatic atrial fibrillation: demographic features and prognostic information from the Atrial Fibrillation Follow‐up Investigation of Rhythm Management (AFFIRM) study. Am Heart J. 2005;149:657–663. - PubMed
-
- Healey JS, Connolly SJ, Gold MR, et al. Subclinical atrial fibrillation and the risk of stroke. N Engl J Med. 2012;366:120–129. - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
